|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||39.31 - 40.03|
|52 Week Range||33.40 - 43.02|
|Beta (3Y Monthly)||0.77|
|PE Ratio (TTM)||9.90|
|Forward Dividend & Yield||3.37 (8.70%)|
|1y Target Est||41.94|
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! The simplest way to invest in stocks is to buy exchange traded funds. But one can do better than that by picking be...
A look at the shareholders of ASR Nederland N.V. (AMS:ASRNL) can tell us which group is most powerful. Insiders often own a large chunk of younger, smaller, companies while hugeRead More...
Attractive stocks have exceptional fundamentals. In the case of ASR Nederland N.V. (AMS:ASRNL), there's is a company with great financial health as well as a an impressive history of performance. Read More...
** A federal judge who has been asked to sign off on the U.S. government's decision to approve CVS Health Corp's acquisition of insurer Aetna Inc said he was "less convinced" than the government that the companies had struck a deal that ensured the merger was legal under antitrust law. ** Debt-laden Indian carrier Jet Airways Ltd is close to finalising a deal under which shareholder Etihad Airways will inject fresh funds, news channel CNBC-TV18 reported, citing sources. ** U.S. oil and gas company Chevron has decided to launch the sale of its stake in Azerbaijan's largest oil field as well as the Baku-Tbilisi-Ceyhan (BTC) pipeline, it said in a statement.
When ASR Nederland NV (AMS:ASRNL) announced its most recent earnings (30 June 2018), I did two things: looked at its past earnings track record, then look at what is happening Read More...
Dividends play a key role in compounding returns over time and can form a large part of our portfolio return. ASR Nederland NV (AMS:ASRNL) has recently paid dividends to shareholders, Read More...
I am writing today to help inform people who are new to the stock market and want to learn about Return on Equity using a real-life example. ASR Nederland NVRead More...
HONG KONG/AMSTERDAM (Reuters) - China's Anbang Insurance Group [ANBANG.UL] has picked JPMorgan to manage the 1.4-1.8 billion euro (1.2-1.6 billion pounds) sale of its Dutch insurance arm Vivat, two people familiar with the matter told Reuters. The Chinese government has been considering the sale of Anbang's overseas real estate and insurance assets, which include Belgian insurer Fidea, since it took control of the troubled company in February. JPMorgan won the mandate after Anbang asked banks to pitch for a role in August, the sources said.JPMorgan declined to comment.
Dutch insurer ASR (ASRNL.AS) said it would consider bidding for Dutch rival Vivat if its Chinese owner Anbang [ANBANG.UL] sells it as part of wider plans to offload European assets. Anbang Insurance Group bought Vivat, which had been nationalised by the Dutch government, for a nominal 1 euro in 2015 and a 1.35 billion euro ($1.54 billion) equity injection. Anbang began vetting investment banks to sell its overseas assets in June, after Chinese authorities took over control of the sprawling conglomerate in February.
A look at the shareholders of ASR Nederland NV (AMS:ASRNL) can tell us which group is most powerful. Large companies usually have institutions as shareholders, and we usually see insidersRead More...